77 related articles for article (PubMed ID: 9014490)
1. [Mechanism of the induction of apoptosis in cancer cells].
Nakaya K
Seikagaku; 1996 Dec; 68(12):1808-12. PubMed ID: 9014490
[No Abstract] [Full Text] [Related]
2. [On the novel differentiation-apoptosis inducers in tumor cells].
Nakaya K
Tanpakushitsu Kakusan Koso; 1996 Feb; 41(2):119-26. PubMed ID: 8685376
[No Abstract] [Full Text] [Related]
3. Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis.
Deng R; Li W; Guan Z; Zhou JM; Wang Y; Mei YP; Li MT; Feng GK; Huang W; Liu ZC; Han Y; Zeng YX; Zhu XF
Oncogene; 2006 Nov; 25(53):7070-7. PubMed ID: 16715131
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction pathways in cancer development and as targets for cancer prevention.
Bode AM; Dong Z
Prog Nucleic Acid Res Mol Biol; 2005; 79():237-97. PubMed ID: 16096030
[No Abstract] [Full Text] [Related]
5. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
[TBL] [Abstract][Full Text] [Related]
6. Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo.
Jain CK; Pradhan BS; Banerjee S; Mondal NB; Majumder SS; Bhattacharyya M; Chakrabarti S; Roychoudhury S; Majumder HK
Sci Rep; 2015 Jul; 5():12082. PubMed ID: 26189912
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design.
Lerner EC; Hamilton AD; Sebti SM
Anticancer Drug Des; 1997 Jun; 12(4):229-38. PubMed ID: 9199657
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.
Okamoto S; Jiang Y; Kawamura K; Shingyoji M; Tada Y; Sekine I; Takiguchi Y; Tatsumi K; Kobayashi H; Shimada H; Hiroshima K; Tagawa M
Cell Death Dis; 2014 Nov; 5(11):e1517. PubMed ID: 25393473
[TBL] [Abstract][Full Text] [Related]
9. Ikaros is degraded by proteasome-dependent mechanism in the early phase of apoptosis induction.
He LC; Xu HZ; Gu ZM; Liu CX; Chen GQ; Wang YF; Wen DH; Wu YL
Biochem Biophys Res Commun; 2011 Mar; 406(3):430-4. PubMed ID: 21329675
[TBL] [Abstract][Full Text] [Related]
10. AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells.
Tsai SC; Lu CC; Lee CY; Lin YC; Chung JG; Kuo SC; Amagaya S; Chen FN; Chen MY; Chan SF; Yang JS
Int J Oncol; 2012 Nov; 41(5):1683-92. PubMed ID: 22922805
[TBL] [Abstract][Full Text] [Related]
11. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun.
Itamochi H; Oishi T; Shimada M; Sato S; Uegaki K; Naniwa J; Sato S; Nonaka M; Terakawa N; Kigawa J; Harada T
Clin Cancer Res; 2011 Jul; 17(14):4742-50. PubMed ID: 21610153
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells.
Beere HM; Chresta CM; Hickman JA
Mol Pharmacol; 1996 May; 49(5):842-51. PubMed ID: 8622634
[TBL] [Abstract][Full Text] [Related]
15. Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells.
Zhao H; Zhao D; Jin H; Li H; Yang X; Zhuang L; Liu T
Mol Med Rep; 2016 Aug; 14(2):1817-22. PubMed ID: 27357249
[TBL] [Abstract][Full Text] [Related]
16. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
[TBL] [Abstract][Full Text] [Related]
17. [Effect of cinobufagin on nuclear factor-kappaB pathway in HepG2 cells].
Dong YQ; Ma WL; Gu JB; Zheng WL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):137-9. PubMed ID: 20118004
[TBL] [Abstract][Full Text] [Related]
18. [Research progress of in vitro and in vivo anti-tumor effects and formulation of bufalin].
Xu Y; Chen M; Jin XF; Qian C; Xu XM; Zhang X
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2829-33. PubMed ID: 25423817
[TBL] [Abstract][Full Text] [Related]
19. The anticancer effect of (1S,2S,3E,7E,11E)-3,7,11, 15-cembratetraen-17,2-olide(LS-1) through the activation of TGF-β signaling in SNU-C5/5-FU, fluorouracil-resistant human colon cancer cells.
Kim EJ; Kang JI; Kwak JW; Jeon CH; Tung NH; Kim YH; Choi CH; Hyun JW; Koh YS; Yoo ES; Kang HK
Mar Drugs; 2015 Mar; 13(3):1340-59. PubMed ID: 25786063
[TBL] [Abstract][Full Text] [Related]
20. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG
Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
